Development of the International Thymic Malignancy Interest Group International Database: An unprecedented resource for the study of a rare group of tumors

Journal of Thoracic Oncology

Volumn 9, Issue 10, 2014, Pages 1573-1578

  Huang, James ^a   Ahmad, Usman ^a   Antonicelli, Alberto ^b   Catlin, Ann Christine ^d   Fang, Wentao ^e   Gomez, Daniel ^f   Loehrer, Patrick ^g   Lucchi, Marco ^h   Marom, Edith ^f   Nicholson, Andrew ⁱ   Ruffini, Enrico ^j   Travis, William ^a   Van Schil, Paul ^k   Wakelee, Heather ^l   Yao, Xiaopan ^c   Detterbeck, Frank ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

^d PURDUE UNIVERSITY   (United States)

^e SHANGHAI CHEST HOSPITAL   (China)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g INDIANA UNIVERSITY   (United States)

^h UNIVERSITY OF PISA   (Italy)

ⁱ ROYAL BROMPTON HOSPITAL   (United Kingdom)

^j UNIVERSITY OF TURIN   (Italy)

^k ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^l STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Database; Thymic carcinoid; Thymic carcinoma; Thymic malignancies; Thymoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; DATA BASE; FEMALE; HUMAN; INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SEX RATIO; THYMIC CARCINOID; THYMOMA; THYMUS CANCER; WORLD HEALTH ORGANIZATION; FACTUAL DATABASE; MIDDLE AGED; PATHOLOGY; PUBLIC OPINION; RETROSPECTIVE STUDY; THYMUS NEOPLASMS; TREATMENT OUTCOME;

DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PUBLIC OPINION; RETROSPECTIVE STUDIES; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 84922284061     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000269     Document Type: Article

References (15)

1. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-2492.
2. Thomas PA. The need for organization and collaboration: establishing a thymoma registry. Thorac Surg Clin 2011;21:131-134, viii.
3. Detterbeck F. International thymic malignancies interest group: a way forward. J Thorac Oncol 2010;5(10 Suppl 4):S365-S370.
4. Goldstraw P, Crowley J, Chansky K, et al.; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714.
5. Detterbeck FC, Asamura H, Crowley J, et al.; Staging and Prognostic Factors Committee; Members of the Advisory Boards; Participating Institutions of the Thymic Domain. The IASLC/ITMIG thymic malignancies staging project: development of a stage classification for thymic malignancies. J Thorac Oncol 2013;8:1467-1473.
6. Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 2003;105:546-551.
7. McLennan M, Kennell R. HUBzero: a platform for dissemination and collaboration in computational science and engineering. Comput Sci Eng 2010;12:48-52.
8. Huang J, Detterbeck FC, Wang Z, Loehrer PJ Sr. Standard outcome measures for thymic malignancies. J Thorac Oncol 2010;5:2017-2023.
9. Koga K, Matsuno Y, Noguchi M, et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994;44:359-367.
10. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. Lyon: IARC Press, 2004.
11. Jaretzki A 3rd, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg 2000;70:327-334.
12. Kondo K, Monden Y. Lymphogenous and hematogenous metastasis of thymic epithelial tumors. Ann Thorac Surg 2003;76:1859-1864.
13. Huang J, Rizk NP, Travis WD, et al. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg 2007;134:1477-1483.
14. Loehrer PJ Sr, Chen M, Kim K, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 1997;15:3093-3099.
15. Korst RJ, Kansler AL, Christos PJ, Mandal S. Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg 2009;87:1641-1647.